Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the pharmaceuticals industry.

People who take popular weight loss drugs like Ozempic can have serious side effects and new research says stopping them can ...